JAGLX holdings — Janus Henderson Global Life Sciences Fund
Janus Henderson Global Life Sciences Fund (JAGLX) held 108 positions with net assets of $5.81B as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 42.4% of the fund, led by LLY, JNJ, ABBV.
JAGLX top holdings
- LLY Eli Lilly & Co. — 9.41% ($546M)
- JNJ Johnson & Johnson — 7.09% ($412M)
- ABBV AbbVie, Inc. — 4.67% ($271M)
- UNH UnitedHealth Group, Inc. — 4.54% ($264M)
- AstraZeneca plc — 3.93% ($228M)
- RVMD Revolution Medicines, Inc. — 3.02% ($175M)
- ARGX Argenx SE — 2.63% ($153M)
- NVS Novartis AG — 2.56% ($149M)
- TMO Thermo Fisher Scientific, Inc. — 2.33% ($135M)
- PRAX Praxis Precision Medicines, Inc. — 2.19% ($127M)
- BBIO Bridgebio Pharma, Inc. — 2.04% ($118M)
- CVS CVS Health Corp. — 2.02% ($117M)
- Roche Holding AG — 2.01% ($117M)
- ISRG Intuitive Surgical, Inc. — 1.94% ($113M)
- MRK Merck & Co., Inc. — 1.87% ($109M)
- ABT Abbott Laboratories — 1.86% ($108M)
- VRTX Vertex Pharmaceuticals, Inc. — 1.69% ($98.3M)
- Ascendis Pharma A/S — 1.68% ($97.5M)
- DHR Danaher Corp. — 1.65% ($95.7M)
- AMGN Amgen, Inc. — 1.64% ($95.1M)
- Sanofi SA — 1.58% ($91.8M)
- SYK Stryker Corp. — 1.41% ($82.0M)
- PTCT PTC Therapeutics, Inc. — 1.40% ($81.2M)
- GILD Gilead Sciences, Inc. — 1.39% ($80.5M)
- TVTX Travere Therapeutics, Inc. — 1.38% ($80.3M)
What are JAGLX's top 10 holdings?
LLY (9.4%), JNJ (7.1%), ABBV (4.7%), UNH (4.5%), AstraZeneca plc (3.9%), RVMD (3.0%), ARGX (2.6%), NVS (2.6%), TMO (2.3%), PRAX (2.2%).
How many stocks are in JAGLX?
Janus Henderson Global Life Sciences Fund reported 108 holdings as of June 30, 2026.
Share classes: JAGLX, JFNAX, JFNCX, JFNIX, JFNNX, JFNSX, JNGLX